Elevation Oncology Stock Technical Analysis
| ELEV Stock | USD 0.60 0.01 1.64% |
As of the 24th of November, Elevation Oncology shows the Mean Deviation of 3.51, standard deviation of 4.5, and Variance of 20.23. Elevation Oncology technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Elevation Oncology mean deviation, treynor ratio, as well as the relationship between the Treynor Ratio and kurtosis to decide if Elevation Oncology is priced favorably, providing market reflects its regular price of 0.6 per share. As Elevation Oncology is a penny stock we also recommend to verify its jensen alpha numbers.
Elevation Oncology Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Elevation, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ElevationElevation |
Elevation Oncology Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 4.83 | Strong Buy | 7 | Odds |
Most Elevation analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Elevation stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Elevation Oncology, talking to its executives and customers, or listening to Elevation conference calls.
Elevation Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Elevation Oncology Technical Analysis
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Elevation Oncology volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Elevation Oncology Trend Analysis
Use this graph to draw trend lines for Elevation Oncology. You can use it to identify possible trend reversals for Elevation Oncology as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Elevation Oncology price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Elevation Oncology Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Elevation Oncology applied against its price change over selected period. The best fit line has a slop of 0.0008 , which may suggest that Elevation Oncology market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.02, which is the sum of squared deviations for the predicted Elevation Oncology price change compared to its average price change.About Elevation Oncology Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Elevation Oncology on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Elevation Oncology based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Elevation Oncology price pattern first instead of the macroeconomic environment surrounding Elevation Oncology. By analyzing Elevation Oncology's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Elevation Oncology's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Elevation Oncology specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 17.0 | 5.93 | 21.22 | 22.28 | Net Debt To EBITDA | 4.57 | 0.17 | 0.46 | 0.44 |
Elevation Oncology November 24, 2024 Technical Indicators
Most technical analysis of Elevation help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Elevation from various momentum indicators to cycle indicators. When you analyze Elevation charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.16) | |||
| Mean Deviation | 3.51 | |||
| Coefficient Of Variation | (1,343) | |||
| Standard Deviation | 4.5 | |||
| Variance | 20.23 | |||
| Information Ratio | (0.10) | |||
| Jensen Alpha | (0.59) | |||
| Total Risk Alpha | (1.05) | |||
| Treynor Ratio | (0.17) | |||
| Maximum Drawdown | 22.21 | |||
| Value At Risk | (8.22) | |||
| Potential Upside | 5.77 | |||
| Skewness | 0.1043 | |||
| Kurtosis | 0.2139 |
Additional Tools for Elevation Stock Analysis
When running Elevation Oncology's price analysis, check to measure Elevation Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevation Oncology is operating at the current time. Most of Elevation Oncology's value examination focuses on studying past and present price action to predict the probability of Elevation Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevation Oncology's price. Additionally, you may evaluate how the addition of Elevation Oncology to your portfolios can decrease your overall portfolio volatility.